A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren\'s syndrome (SS).
Epistemonikos ID: 986ba59f4fa45e645fb1939cd87ee989ce212094
First added on: May 15, 2024